ANXA5 predicts prognosis and immune response and mediates proliferation and migration in head and neck squamous cell carcinoma
Through bioinformatics, a prognostic risk model of high precision was developed, offering valuable insights into the survival rates and immune responses in patients with HNSCC. ANXA5 is highlighted as a significant prognostic factor among the identified genes, indicating its promise as a potential therapeutic target for those with HNSCC.
Authors
- Zheng Zhou (ORCID: https://orcid.org/0000-0003-3351-641X)
- Huikuan Chen
- Jinfei Guo
- Donghui Yang
Institutions
- Guangdong Medical College (CN)
- Hunan Children's Hospital (CN)
- Gaozhou People's Hospital (CN)
Publication Details
- Journal
- Gene
- Published
- 2024-08-22
- DOI
- https://doi.org/10.1016/j.gene.2024.148867
- Citations
- 7
- Primary Topic
- S100 Proteins and Annexins
- Type
- article
- Field-Weighted Citation Impact
- 1.64